Recent News

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

November 24, 2020
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical… Continue Reading →

Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership With The Chase Group

November 16, 2020
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually… Continue Reading →

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →

Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs, for Akcea Therapeutics

July 23, 2020
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,… Continue Reading →

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

July 10, 2020
The Chase Group, known for relationship building with proven success in life sciences executive search, was retained by Akcea Therapeutics, to identify and secure a… Continue Reading →

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

May 18, 2020
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson… Continue Reading →

Akcea Therapeutics Turns to The Chase Group to Secure Chief Medical Officer

April 29, 2020
Akcea Therapeutics is focused on helping patients living with rare diseases by understanding patient and physician needs by bringing transformative medicines to market. Akcea is… Continue Reading →

Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

March 31, 2020
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their… Continue Reading →

Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs

March 26, 2020
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As… Continue Reading →

A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

March 24, 2020
At the crossroads of innovation and advanced technology, Alexza Pharmaceuticals is working to develop products for the acute treatment of underserved medical needs in neuroscience…. Continue Reading →
Copyright © 1993-2025 The Chase Group. All Rights Reserved.